Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DISCO: Disulfiram for COVID-19
NCT04485130Phase 2Terminated
- Sponsor
- University of California, San Francisco
- Start
- Aug 2021
- Primary completion
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in coronavirus disease 2019 (COVID-19) comparing Disulfiram with Placebo (2 arms). Primary endpoint: Immunologic Impact of 5 Days of Disulfiram (Fold-change in Plasma Levels of Pro-inflammatory Cytokines) at Day 31. Started Aug 2021; status: terminated.
02
Drugs
disulfiram
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04485130.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04485130.